Argyreia nervosa exposures reported to Texas poison centers. Issue 3 (2nd October 2018)

• Record Type: Journal Article
• Authors: Forrester, Mathias B.
• Is Part Of: Journal of addictive diseases. Volume 37:Issue 3/4(2018)
• Page Start: 160
• Page End: 164
• Publication Date: 2018-10-02
• Subjects: Argyreia nervosa -- Hawaiian baby woodrose -- lysergic acid amine -- poison center; Substance abuse -- Periodicals; Drug abuse -- Periodicals; Alcoholism -- Periodicals; Compulsive behavior -- Periodicals; 362.2905
• DOI: 10.1080/10550887.2019.1640057
• Languages: English
• ISSNs: 1055-0887

Abstract

Abstract: The seeds of Argyreia nervosa (Hawaiian baby woodrose) contain lysergamide or lysergic acid amine, an analog for lysergic acid diethylamide. Twenty-nine Argyreia nervosa exposures reported to Texas poison centers during 2000–2018 were identified. Seventy-nine percent of the patients were male; the mean age was 24 years (range 16–53 years). The exposure route was 97% ingestion and 3% inhalation. Ninety-three percent of the exposures occurred at the patient's own residence and 3% at another residence. Fourteen percent of the patients were managed on-site, 69% were already at or en route to a healthcare facility when the poison center was contacted, and 17% were referred to a healthcare facility by the poison center. The medical outcome was 3% no effect, 31% minor effect, 38% moderate effect, 7% major effect, 7% not followed-minimal clinical effects possible, and 14% unable to follow-potentially toxic. The most frequent clinical effects were gastrointestinal (45%) and neurological (41%). The most frequently reported treatments were administration of intravenous fluids (28%) and benzodiazepines (21%).